Upgrades
Raymond James upgraded the previous rating for Extra Space Storage Inc (NYSE:EXR) from Outperform to Strong Buy. Extra Space Storage earned $2.09 in the fourth quarter, compared to $1.91 in the year-ago quarter. The stock has a 52-week-high of $222.15 and a 52-week-low of $139.97. At the end of the last trading period, Extra Space Storage closed at $154.51.
According to Raymond James, the prior rating for AeroVironment Inc (NASDAQ:AVAV) was changed from Outperform to Strong Buy. For the third quarter, AeroVironment had an EPS of $0.33, compared to year-ago quarter EPS of $0.32. The current stock performance of AeroVironment shows a 52-week-high of $114.07 and a 52-week-low of $70.08. Moreover, at the end of the last trading period, the closing price was at $91.95.
Loop Capital upgraded the previous rating for Burlington Stores Inc (NYSE:BURL) from Hold to Buy. In the fourth quarter, Burlington Stores showed an EPS of $2.96, compared to $2.53 from the year-ago quarter. The stock has a 52-week-high of $239.94 and a 52-week-low of $106.81. At the end of the last trading period, Burlington Stores closed at $205.93.
Morgan Stanley upgraded the previous rating for CSX Corp (NASDAQ:CSX) from Underweight to Equal-Weight. For the fourth quarter, CSX had an EPS of $0.49, compared to year-ago quarter EPS of $0.42. The stock has a 52-week-high of $38.15 and a 52-week-low of $25.81. At the end of the last trading period, CSX closed at $29.85.
Morgan Stanley upgraded the previous rating for Norfolk Southern Corp (NYSE:NSC) from Underweight to Equal-Weight. Norfolk Southern earned $3.42 in the fourth quarter, compared to $3.12 in the year-ago quarter. The stock has a 52-week-high of $285.48 and a 52-week-low of $196.33. At the end of the last trading period, Norfolk Southern closed at $208.78.
For Health Catalyst Inc (NASDAQ:HCAT), Wells Fargo upgraded the previous rating of Equal-Weight to Overweight. In the fourth quarter, Health Catalyst showed an EPS of $0.05, compared to $0.19 from the year-ago quarter. The current stock performance of Health Catalyst shows a 52-week-high of $27.98 and a 52-week-low of $6.41. Moreover, at the end of the last trading period, the closing price was at $11.87.
For Etsy Inc (NASDAQ:ETSY), Piper Sandler upgraded the previous rating of Neutral to Overweight. In the fourth quarter, Etsy showed an EPS of $0.77, compared to $1.11 from the year-ago quarter. The stock has a 52-week-high of $149.91 and a 52-week-low of $67.06. At the end of the last trading period, Etsy closed at $108.25.
For ONEOK Inc (NYSE:OKE), Citigroup upgraded the previous rating of Neutral to Buy. ONEOK earned $1.08 in the fourth quarter, compared to $0.85 in the year-ago quarter. At the moment, the stock has a 52-week-high of $75.06 and a 52-week-low of $50.51. ONEOK closed at $65.06 at the end of the last trading period.
For ServiceNow Inc (NYSE:NOW), Baird upgraded the previous rating of Neutral to Outperform. In the fourth quarter, ServiceNow showed an EPS of $2.28, compared to $1.46 from the year-ago quarter. The current stock performance of ServiceNow shows a 52-week-high of $575.64 and a 52-week-low of $337.05. Moreover, at the end of the last trading period, the closing price was at $464.49.
JP Morgan upgraded the previous rating for Prudential Financial Inc (NYSE:PRU) from Neutral to Overweight. In the fourth quarter, Prudential Financial showed an EPS of $2.42, compared to $3.18 from the year-ago quarter. The stock has a 52-week-high of $122.54 and a 52-week-low of $75.37. At the end of the last trading period, Prudential Financial closed at $82.43.
According to Goldman Sachs, the prior rating for Corebridge Financial Inc (NYSE:CRBG) was changed from Neutral to Buy. Corebridge Financial earned $0.88 in the fourth quarter, compared to $1.13 in the year-ago quarter. The stock has a 52-week-high of $23.49 and a 52-week-low of $14.01. At the end of the last trading period, Corebridge Financial closed at $15.56.
Exane BNP Paribas upgraded the previous rating for Chevron Corp (NYSE:CVX) from Underperform to Neutral. Chevron earned $4.09 in the fourth quarter, compared to $2.56 in the year-ago quarter. At the moment, the stock has a 52-week-high of $189.66 and a 52-week-low of $132.54. Chevron closed at $169.95 at the end of the last trading period.
Morgan Stanley upgraded the previous rating for Evotec SE (NASDAQ:EVO) from Underweight to Equal-Weight. The current stock performance of Evotec shows a 52-week-high of $15.59 and a 52-week-low of $7.80. Moreover, at the end of the last trading period, the closing price was at $10.71.
For WideOpenWest Inc (NYSE:WOW), Keybanc upgraded the previous rating of Sector Weight to Overweight. In the fourth quarter, WideOpenWest showed an EPS of $0.15, compared to $0.01 from the year-ago quarter. At the moment, the stock has a 52-week-high of $22.89 and a 52-week-low of $8.57. WideOpenWest closed at $10.34 at the end of the last trading period.
According to Keybanc, the prior rating for Comcast Corp (NASDAQ:CMCSA) was changed from Sector Weight to Overweight. Comcast earned $0.82 in the fourth quarter, compared to $0.77 in the year-ago quarter. The stock has a 52-week-high of $48.42 and a 52-week-low of $28.39. At the end of the last trading period, Comcast closed at $38.01.
See all analyst ratings upgrades.
Downgrades
For Oncternal Therapeutics Inc (NASDAQ:ONCT), Maxim Group downgraded the previous rating of Buy to Hold. For the fourth quarter, Oncternal Therapeutics had an EPS of $0.20, compared to year-ago quarter EPS of $0.16. The current stock performance of Oncternal Therapeutics shows a 52-week-high of $1.85 and a 52-week-low of $0.60. Moreover, at the end of the last trading period, the closing price was at $0.79.
According to Brookline Capital, the prior rating for Oncternal Therapeutics Inc (NASDAQ:ONCT) was changed from Buy to Hold. For the fourth quarter, Oncternal Therapeutics had an EPS of $0.20, compared to year-ago quarter EPS of $0.16. The current stock performance of Oncternal Therapeutics shows a 52-week-high of $1.85 and a 52-week-low of $0.60. Moreover, at the end of the last trading period, the closing price was at $0.79.
According to SVB Leerink, the prior rating for Pardes Biosciences Inc (NASDAQ:PRDS) ...Full story available on Benzinga.com
Benzinga